FIELD: medicine, pharmacy, biotechnology.
SUBSTANCE: invention relates to a novel biologically active substance comprising a complex of humoral factors of allogenic diploid fibroblasts. This substance is prepared by mechanical homogenization of donor tissue with addition of nutrient medium, culturing in wet atmosphere with 5% of CO2 and separation of supernatant fraction. Invention provides decreasing limitations in using and decreasing cost in preparing the proposed substance. Invention can be used in preparing medicinal agents possessing anti-inflammatory, immunomodulating and wound-healing properties.
EFFECT: valuable medicinal properties of substance, improved preparing method.
2 tbl, 10 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR LOCAL TREATMENT OF EROSIVE-ULCEROUS DEFECTS OF SKIN AND MUCOSA | 2003 |
|
RU2250108C2 |
HUMAN FIBROBLAST-BASED SUPERNATANT MEDICINE WITH WOUND HEALING ACTIVITY | 2007 |
|
RU2369398C2 |
METHOD FOR TREATING BURN WOUNDS | 1998 |
|
RU2157269C2 |
METHOD FOR TREATING PERITONITIS | 2000 |
|
RU2169570C1 |
ANTI-ENTEROVIRAL AND IMMUNOSTIMULATING AGENT | 2014 |
|
RU2554761C1 |
METHOD OF EVALUATING IMMUNOGENECITY OF ANTI-BRICELLOSIS VACCINE STRAINS | 2009 |
|
RU2419096C2 |
CO-DIFFERENTIATION OF MONOCYTES FROM ALLOGENEIC DONORS | 2013 |
|
RU2668816C2 |
MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD FOR IDENTIFYING FUNCTIONAL M1 AND M2 PHENOTYPE OF HUMAN MACROPHAGES GENERATED IN VITRO FROM BLOOD MONOCYTES | 2019 |
|
RU2717024C1 |
Authors
Dates
2007-06-10—Published
2005-01-31—Filed